Kudela P - Search Results

1

Bacterial ghosts as adjuvant to oxaliplatin chemotherapy in colorectal carcinomatosis.

Groza D, Gehrig S, Kudela P, Holcmann M, Pirker C, Dinhof C, Schueffl HH, Sramko M, Hoebart J, Alioglu F, Grusch M, Ogris M, Lubitz W, Keppler BK, Pashkunova-Martic I, Kowol CR, Sibilia M, Berger W, Heffeter P. Groza D, et al. Among authors: kudela p. Oncoimmunology. 2018 Feb 16;7(5):e1424676. doi: 10.1080/2162402X.2018.1424676. eCollection 2018. Oncoimmunology. 2018. PMID: 29721389 Free PMC article.

2

Bacterial ghosts (BGs)--advanced antigen and drug delivery system.

Kudela P, Koller VJ, Lubitz W. Kudela P, et al. Vaccine. 2010 Aug 16;28(36):5760-7. doi: 10.1016/j.vaccine.2010.06.087. Epub 2010 Jul 7. Vaccine. 2010. PMID: 20619379 Review.

3

Bacterial ghosts as carriers of protein subunit and DNA-encoded antigens for vaccine applications.

Muhammad A, Champeimont J, Mayr UB, Lubitz W, Kudela P. Muhammad A, et al. Among authors: kudela p. Expert Rev Vaccines. 2012 Jan;11(1):97-116. doi: 10.1586/erv.11.149. Expert Rev Vaccines. 2012. PMID: 22149712 Review.

4

Modulation of bacterial ghosts--induced nitric oxide production in macrophages by bacterial ghost-delivered resveratrol.

Koller VJ, Dirsch VM, Beres H, Donath O, Reznicek G, Lubitz W, Kudela P. Koller VJ, et al. Among authors: kudela p. FEBS J. 2013 Mar;280(5):1214-25. doi: 10.1111/febs.12112. Epub 2013 Jan 31. FEBS J. 2013. PMID: 23289719 Free article.

5

Rectal single dose immunization of mice with Escherichia coli O157:H7 bacterial ghosts induces efficient humoral and cellular immune responses and protects against the lethal heterologous challenge.

Mayr UB, Kudela P, Atrasheuskaya A, Bukin E, Ignatyev G, Lubitz W. Mayr UB, et al. Among authors: kudela p. Microb Biotechnol. 2012 Mar;5(2):283-94. doi: 10.1111/j.1751-7915.2011.00316.x. Epub 2011 Nov 22. Microb Biotechnol. 2012. PMID: 22103353 Free PMC article.

6

Oncolysate-loaded Escherichia coli bacterial ghosts enhance the stimulatory capacity of human dendritic cells.

Michalek J, Hezova R, Turanek-Knötigova P, Gabkova J, Strioga M, Lubitz W, Kudela P. Michalek J, et al. Among authors: kudela p. Cancer Immunol Immunother. 2017 Feb;66(2):149-159. doi: 10.1007/s00262-016-1932-4. Epub 2016 Nov 18. Cancer Immunol Immunother. 2017. PMID: 27864613 Free PMC article.

7

Bacterial ghosts as a novel advanced targeting system for drug and DNA delivery.

Paukner S, Stiedl T, Kudela P, Bizik J, Al Laham F, Lubitz W. Paukner S, et al. Among authors: kudela p. Expert Opin Drug Deliv. 2006 Jan;3(1):11-22. doi: 10.1517/17425247.3.1.11. Expert Opin Drug Deliv. 2006. PMID: 16370937 Review.

8

Escherichia coli ghosts promote innate immune responses in human keratinocytes.

Abtin A, Kudela P, Mayr UB, Koller VJ, Mildner M, Tschachler E, Lubitz W. Abtin A, et al. Among authors: kudela p. Biochem Biophys Res Commun. 2010 Sep 10;400(1):78-82. doi: 10.1016/j.bbrc.2010.08.013. Epub 2010 Aug 7. Biochem Biophys Res Commun. 2010. PMID: 20696136

9

The Bacterial Ghost platform system: production and applications.

Langemann T, Koller VJ, Muhammad A, Kudela P, Mayr UB, Lubitz W. Langemann T, et al. Among authors: kudela p. Bioeng Bugs. 2010 Sep-Oct;1(5):326-36. doi: 10.4161/bbug.1.5.12540. Bioeng Bugs. 2010. PMID: 21326832 Free PMC article. Review.

10

Bacterial Ghosts as antigen and drug delivery system for ocular surface diseases: Effective internalization of Bacterial Ghosts by human conjunctival epithelial cells.

Kudela P, Koller VJ, Mayr UB, Nepp J, Lubitz W, Barisani-Asenbauer T. Kudela P, et al. J Biotechnol. 2011 May 20;153(3-4):167-75. doi: 10.1016/j.jbiotec.2011.03.022. Epub 2011 Apr 8. J Biotechnol. 2011. PMID: 21501636

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

54 results

Search Page